Equities

Tian'an Pharmaceutical Co Ltd

TNPH:PKL

Tian'an Pharmaceutical Co Ltd

Actions
  • Price (USD)0.0052
  • Today's Change0.00 / 0.00%
  • Shares traded20.50k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Oct 09 2024 16:53 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Tian'an Pharmaceutical Co Ltd grew revenues 50.51% from 7.08m to 10.65m while net income improved 106.71% from 1.52m to 3.14m.
Gross margin68.54%
Net profit margin29.51%
Operating margin34.73%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2007, Tian'an Pharmaceutical Co Ltd increased its cash reserves by 58.47%, or 3.04m. The company earned 2.56m from its operations for a Cash Flow Margin of 24.06%. In addition the company used 7.00k on investing activities and also paid in financing cash flows.
Cash flow per share0.2602
Price/Cash flow per share1.14
Book value per share1.03
Tangible book value per share0.9484
More ▼

Balance sheet in USDView more

Tian'an Pharmaceutical Co Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio14.23
Quick ratio13.36
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 106.71%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
106.78
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.